Two Sigma Advisers’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,180
| Closed | -$44.8K | – | 2712 |
|
|
2023
Q4 | $44.8K | Sell |
4,180
-740
| -15% | -$7.94K | ﹤0.01% | 2409 |
|
|
2023
Q3 | $29.5K | Sell |
4,920
-1,475
| -23% | -$8.85K | ﹤0.01% | 2309 |
|
|
2023
Q2 | $44.1K | Sell |
6,395
-90
| -1% | -$621 | ﹤0.01% | 2282 |
|
|
2023
Q1 | $102K | Sell |
6,485
-4,270
| -40% | -$67K | ﹤0.01% | 2381 |
|
|
2022
Q4 | $215K | Sell |
10,755
-4,005
| -27% | -$80.1K | ﹤0.01% | 2164 |
|
|
2022
Q3 | $263K | Buy |
14,760
+8,005
| +119% | +$143K | ﹤0.01% | 2105 |
|
|
2022
Q2 | $150K | Buy |
6,755
+1,980
| +41% | +$44K | ﹤0.01% | 2335 |
|
|
2022
Q1 | $133K | Buy |
4,775
+4,235
| +784% | +$118K | ﹤0.01% | 2453 |
|
|
2021
Q4 | $25K | Sell |
540
-5,690
| -91% | -$263K | ﹤0.01% | 2537 |
|
|
2021
Q3 | $520K | Buy |
6,230
+3,295
| +112% | +$275K | ﹤0.01% | 1912 |
|
|
2021
Q2 | $279K | Buy |
2,935
+755
| +35% | +$71.8K | ﹤0.01% | 2162 |
|
|
2021
Q1 | $363K | Buy |
+2,180
| New | +$363K | ﹤0.01% | 2150 |
|
|
2019
Q2 | – | Sell |
-381
| Closed | -$64K | – | 2479 |
|
|
2019
Q1 | $64K | Buy |
381
+55
| +17% | +$9.24K | ﹤0.01% | 2222 |
|
|
2018
Q4 | $36K | Buy |
+326
| New | +$36K | ﹤0.01% | 2295 |
|